Canada inks deal to buy 1.5 million Pfizer and Merck antiviral medication, pending approval from Health Canada.
Procurement Minister Filomena Tassi says the federal government has signed on to purchase antiviral COVID-19 drugs from Pfizer and Merck, pending approval of the products from Health Canada.
Tassi told reporters today that Ottawa has ordered one million of the Pfizer pills and 500,000 of Merck's medication, with an option for 500,000 more.
Earlier this week, Pfizer submitted an approval request to Health Canada.
Meanwhile, Merck's clinical trial indicated a 50 percent reduced risk of death or hospitalization for placebo patients with mild or moderate COVID-19.
City Encouraged to Go After Funding
Cost of Renewing Vows Could Rise
GM Investing in St. Catharines
NRP Investigating Fatal Pelham Crash
NRP Officers Praised by Management
945 Supportive Housing Units Approved
Niagara Talks Canadian Defense
Niagara Falls Expecting More Evacuees